WebJan 18, 2024 · See the latest Chugai Pharmaceutical Co Ltd stock price (PINX:CHGCF), related news, valuation, dividends and more to help you make your investing decisions. WebApr 10, 2024 · Jefferies Adjusts Chugai Pharmaceutical's Price Target to 3,900 Yen From 4,200 Yen, Keeps at Buy: MT. 03/31: Chugai Pharmaceutical to Award Restricted Stock Compensation: MT. 03/31: Chugai Pharmaceutical : Voting Results (Extraordinary Report) of the 112th Annual General Meeting of Shareholders ... TOKYO, February 3, 2024 - …
CHGCY: Chugai Pharmaceutical Co Ltd Stock Price Quote - OTC US …
WebMar 24, 2024 · Get Chugai Pharmaceutical Co Ltd (CHGCY:Grey Market) real-time stock quotes, news, price and financial information from CNBC. WebMar 30, 2024 · Chugai Pharmaceutical Co Ltd (CHGCF) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Chugai Pharmaceutical Co Ltd lowest stock price was $22.14 and its highest was $34.39 in the past 12 months. What is Chugai Pharmaceutical Co … gillion and the tidestriders
Chugai Pharmaceutical Co Ltd ADR CHGCY Stock Quote
WebMar 30, 2024 · Get Chugai Pharmaceutical Co Ltd (CHGCF:OTCPK) real-time stock quotes, news, price and financial information from CNBC. Web1 day ago · Delayed Berne Stock Exchange ... [38] Chugai Pharmaceutical Co. Ltd. Chugai obtains regulatory approval for Vabysmo, the first bispecific antibody in ophthalmology, for nAMD and DME [Internet; cited April 2024]. ... Last Close Price: 275,40 CHF: Average target price: 342,78 CHF: Spread / Average Target: 24,5%: Consensus. … WebApr 10, 2024 · Stock Hunter’s View. ... The drug discovery support business saw sales rise thanks to orders from domestic pharmaceutical companies. 12/2024 BPS halved yoy. × ... However, In October 2024, Chugai terminated the Telomelysin licence agreement, so the company will take over clinical trials from Chugai. Phase 2 of the clinical trial for ... gillion and chip